RHAPSIDO 25 mg/1
remibrutinib · TABLET · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
RHAPSIDO is a tablet containing remibrutinib at 25 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- RHAPSIDO
- Generic Name
- remibrutinib
- NDC Code (Product)
0078-1483- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 25 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA218436
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 09/30/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is RHAPSIDO used for?
RHAPSIDO contains remibrutinib. It is a tablet taken oral. Consult your doctor for specific uses.
Is RHAPSIDO a controlled substance?
RHAPSIDO is not classified as a controlled substance by the DEA.
What is the generic name for RHAPSIDO?
The generic name for RHAPSIDO is remibrutinib. There are no other listed brand versions of remibrutinib.
What is the NDC code for RHAPSIDO 25 mg/1?
The NDC (National Drug Code) for RHAPSIDO 25 mg/1 is 0078-1483, listed by Novartis Pharmaceuticals Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)